In last trading session, Generation Bio Co (NASDAQ:GBIO) saw 96822.0 shares changing hands with its beta currently measuring 2.65. Company’s recent per share price level of $1.43 trading at -$0.01 or -0.69% at ring of the bell on the day assigns it a market valuation of $95.51M. That closing price of GBIO’s stock is at a discount of -225.17% from its 52-week high price of $4.65 and is indicating a premium of 23.08% from its 52-week low price of $1.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.18 million shares which gives us an average trading volume of 129.84K if we extend that period to 3-months.
For Generation Bio Co (GBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.86. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.23 in the current quarter.
Generation Bio Co (NASDAQ:GBIO) trade information
Upright in the red during last session for losing -0.69%, in the last five days GBIO remained trading in the green while hitting it’s week-highest on Monday, 11/25/24 when the stock touched $1.43 price level, adding 8.33% to its value on the day. Generation Bio Co’s shares saw a change of -13.33% in year-to-date performance and have moved 5.93% in past 5-day. Generation Bio Co (NASDAQ:GBIO) showed a performance of -40.17% in past 30-days. Number of shares sold short was 1.48 million shares which calculate 10.54 days to cover the short interests.
Generation Bio Co (GBIO) estimates and forecasts
Statistics highlight that Generation Bio Co is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -56.00% of value to its shares in past 6 months, showing an annual growth rate of 10.71% while that of industry is 17.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 207.23% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 2.92M for the same. And 4 analysts are in estimates of company making revenue of 1.4M in the next quarter. Company posted 2.88M and 4.06M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -20.44% during past 5 years.
Generation Bio Co (NASDAQ:GBIO)’s Major holders
Insiders are in possession of 14.51% of company’s total shares while institution are holding 83.88 percent of that, with stock having share float percentage of 98.12%. Investors also watch the number of corporate investors in a company very closely, which is 83.88% institutions for Generation Bio Co that are currently holding shares of the company. PRICE T ROWE ASSOCIATES INC /MD/ is the top institutional holder at GBIO for having 9.51 million shares of worth $26.83 million. And as of 2024-06-30, it was holding 14.3205 of the company’s outstanding shares.
The second largest institutional holder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, which was holding about 8.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.4628 of outstanding shares, having a total worth of $23.35 million.
